“Recombinant deoxyribonucleoside kinase from Drosophila melanogaster can improve gemcitabine based combined gene/chemotherapy for targeting cancer cells” (2019) Biomolecules and Biomedicine, 19(4), pp. 342–349. doi:10.17305/bjbms.2019.4136.